Cargando…

Edaravone Improves Streptozotocin-Induced Memory Impairment via Alleviation of Behavioral Dysfunction, Oxidative Stress, Inflammation, and Histopathological Parameters

Alzheimer's disease (AD), as the main cause of dementia, has a progressive and neurodegenerative pattern with number of cases increasing over the next decades. Therefore, discovering an effective treatment with the ability to invert memory impairment and pathophysiological events of AD seems to...

Descripción completa

Detalles Bibliográficos
Autores principales: Anoush, Mahdieh, Bijani, Soroush, Moslemifar, Fatemeh, Jahanpour, Fatemeh, Kalantari-Hesari, Ali, Hosseini, Mir-Jamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356234/
https://www.ncbi.nlm.nih.gov/pubmed/37476485
http://dx.doi.org/10.1155/2023/9652513
_version_ 1785075220651966464
author Anoush, Mahdieh
Bijani, Soroush
Moslemifar, Fatemeh
Jahanpour, Fatemeh
Kalantari-Hesari, Ali
Hosseini, Mir-Jamal
author_facet Anoush, Mahdieh
Bijani, Soroush
Moslemifar, Fatemeh
Jahanpour, Fatemeh
Kalantari-Hesari, Ali
Hosseini, Mir-Jamal
author_sort Anoush, Mahdieh
collection PubMed
description Alzheimer's disease (AD), as the main cause of dementia, has a progressive and neurodegenerative pattern with number of cases increasing over the next decades. Therefore, discovering an effective treatment with the ability to invert memory impairment and pathophysiological events of AD seems to be required. The present study performed to investigate the probable effects of Edaravone (EDV) in AD-like disorder induced by intracerebroventricular streptozotocin (ICV-STZ) administration in mice. This study also compares the two different methods of ICV-STZ in the memory impairment induction. NMRI male mice were administrated with 3 mg/kg of STZ for two times during 48 hours span, and after 24 hours, animals were treated with EDV (5 and 10 mg/kg), Donepezil, and Memantine for 14 days. After behavioral tests regarding memory and cognitive function, animals were sacrificed, and the hippocampi were utilized for further analyses. Our results demonstrated that administration of STZ induced memory impairment in the Morris water maze (MWM) test and decreased the discriminative factor in novel object recognition (NOR). The biochemical output shows a significant decrease in ferric reducing antioxidant power (FRAP) and glutathione (GSH) levels followed by increase in malondialdehyde (MDA) and protein carbonylation (PCO) levels. The output showed no difference between the patterns of AD-like disorder induction. Following our treatment groups, administration of EDV (5 and 10 mg/kg), Donepezil, and Memantine significantly improved memory performance and discriminatory behavior. Aforementioned treatments managed to improve FRAP and GSH content of hippocampus, while significantly attenuating MDA, PCO, and nitric oxide overproduction. In addition, no significant difference has been observed between the effect of 5 and 10 mg/kg EDV application. It was supposed that EDV managed to ameliorate memory dysfunction, discriminatory behavior, oxidative stress, and cellular antioxidant power in a dose-independent pattern in mice.
format Online
Article
Text
id pubmed-10356234
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103562342023-07-20 Edaravone Improves Streptozotocin-Induced Memory Impairment via Alleviation of Behavioral Dysfunction, Oxidative Stress, Inflammation, and Histopathological Parameters Anoush, Mahdieh Bijani, Soroush Moslemifar, Fatemeh Jahanpour, Fatemeh Kalantari-Hesari, Ali Hosseini, Mir-Jamal Behav Neurol Research Article Alzheimer's disease (AD), as the main cause of dementia, has a progressive and neurodegenerative pattern with number of cases increasing over the next decades. Therefore, discovering an effective treatment with the ability to invert memory impairment and pathophysiological events of AD seems to be required. The present study performed to investigate the probable effects of Edaravone (EDV) in AD-like disorder induced by intracerebroventricular streptozotocin (ICV-STZ) administration in mice. This study also compares the two different methods of ICV-STZ in the memory impairment induction. NMRI male mice were administrated with 3 mg/kg of STZ for two times during 48 hours span, and after 24 hours, animals were treated with EDV (5 and 10 mg/kg), Donepezil, and Memantine for 14 days. After behavioral tests regarding memory and cognitive function, animals were sacrificed, and the hippocampi were utilized for further analyses. Our results demonstrated that administration of STZ induced memory impairment in the Morris water maze (MWM) test and decreased the discriminative factor in novel object recognition (NOR). The biochemical output shows a significant decrease in ferric reducing antioxidant power (FRAP) and glutathione (GSH) levels followed by increase in malondialdehyde (MDA) and protein carbonylation (PCO) levels. The output showed no difference between the patterns of AD-like disorder induction. Following our treatment groups, administration of EDV (5 and 10 mg/kg), Donepezil, and Memantine significantly improved memory performance and discriminatory behavior. Aforementioned treatments managed to improve FRAP and GSH content of hippocampus, while significantly attenuating MDA, PCO, and nitric oxide overproduction. In addition, no significant difference has been observed between the effect of 5 and 10 mg/kg EDV application. It was supposed that EDV managed to ameliorate memory dysfunction, discriminatory behavior, oxidative stress, and cellular antioxidant power in a dose-independent pattern in mice. Hindawi 2023-07-12 /pmc/articles/PMC10356234/ /pubmed/37476485 http://dx.doi.org/10.1155/2023/9652513 Text en Copyright © 2023 Mahdieh Anoush et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Anoush, Mahdieh
Bijani, Soroush
Moslemifar, Fatemeh
Jahanpour, Fatemeh
Kalantari-Hesari, Ali
Hosseini, Mir-Jamal
Edaravone Improves Streptozotocin-Induced Memory Impairment via Alleviation of Behavioral Dysfunction, Oxidative Stress, Inflammation, and Histopathological Parameters
title Edaravone Improves Streptozotocin-Induced Memory Impairment via Alleviation of Behavioral Dysfunction, Oxidative Stress, Inflammation, and Histopathological Parameters
title_full Edaravone Improves Streptozotocin-Induced Memory Impairment via Alleviation of Behavioral Dysfunction, Oxidative Stress, Inflammation, and Histopathological Parameters
title_fullStr Edaravone Improves Streptozotocin-Induced Memory Impairment via Alleviation of Behavioral Dysfunction, Oxidative Stress, Inflammation, and Histopathological Parameters
title_full_unstemmed Edaravone Improves Streptozotocin-Induced Memory Impairment via Alleviation of Behavioral Dysfunction, Oxidative Stress, Inflammation, and Histopathological Parameters
title_short Edaravone Improves Streptozotocin-Induced Memory Impairment via Alleviation of Behavioral Dysfunction, Oxidative Stress, Inflammation, and Histopathological Parameters
title_sort edaravone improves streptozotocin-induced memory impairment via alleviation of behavioral dysfunction, oxidative stress, inflammation, and histopathological parameters
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356234/
https://www.ncbi.nlm.nih.gov/pubmed/37476485
http://dx.doi.org/10.1155/2023/9652513
work_keys_str_mv AT anoushmahdieh edaravoneimprovesstreptozotocininducedmemoryimpairmentviaalleviationofbehavioraldysfunctionoxidativestressinflammationandhistopathologicalparameters
AT bijanisoroush edaravoneimprovesstreptozotocininducedmemoryimpairmentviaalleviationofbehavioraldysfunctionoxidativestressinflammationandhistopathologicalparameters
AT moslemifarfatemeh edaravoneimprovesstreptozotocininducedmemoryimpairmentviaalleviationofbehavioraldysfunctionoxidativestressinflammationandhistopathologicalparameters
AT jahanpourfatemeh edaravoneimprovesstreptozotocininducedmemoryimpairmentviaalleviationofbehavioraldysfunctionoxidativestressinflammationandhistopathologicalparameters
AT kalantarihesariali edaravoneimprovesstreptozotocininducedmemoryimpairmentviaalleviationofbehavioraldysfunctionoxidativestressinflammationandhistopathologicalparameters
AT hosseinimirjamal edaravoneimprovesstreptozotocininducedmemoryimpairmentviaalleviationofbehavioraldysfunctionoxidativestressinflammationandhistopathologicalparameters